CIK 0000879407 · Large accelerated filer
ARROWHEAD PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ARWR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 460408024
- Phone
- 626-696-4702
- Business address
- 177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
- Former names
- ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
- 8-K Event Material agreement · New debt or obligation
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 4 Grant or award Chief Medical Officer acquired 75,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 75,000 shares (grant or award)
- 4 Grant or award COO acquired 75,000 shares (grant or award)
- 305B2 Other 305B2
- FWP Offering Free Writing Prospectus
- FWP Offering Free Writing Prospectus
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 8-K Event Regulation FD disclosure · Other events
- 4 Planned sale COO sold 49,493 shares at an average $63.11 ($3,123,349)
- 4 Planned sale Chief Medical Officer sold 40,164 shares at an average $63.11 ($2,534,661)
- 4 Planned sale Chief Executive Officer sold 13,187 shares at an average $66.10 ($871,703)
- 144/A Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
Page 3 of 69 · 1,361 filings